postpartum pain. Maternal care for other conditions predominantly related to pregnancy
Conditions
Interventions
Intervention 1: Group 2: One hour after childbirth, they were given a capsule of Mefenamic acid to relief their pain. The participants were given another dose of the drugs if their pain relapsed. This
Treatment - Drugs
Group 2: One hour after childbirth, they were given a capsule of Mefenamic acid to relief their pain. The participants were given another dose of the drugs if their pain relapsed. This process was rep
Group 1: One hour after childbirth, they were given a capsule of Menstrogl to relief their pain. The participants were given another dose of the drug if their pain relapsed. This process was repeated
Sponsors
Goldaru Company
Shahid Beheshti University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
17 Years to 35 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Participants were 17-35 years old women; primary or multiparous women who suffer from postpatum pain (scored more than 4 degree based on Visual scale and need to use narcotics); they had normal vaginal delivery; they had not any complication during childbirth, such as using vacuum or forceps, perineal laceration, prolonged labor, Neonate weight more than 3500g, birth of twins or more than one fetuses, using analgesics in previous 2 weeks; they had alive childbirth; infant without malformation; not using any drug in the ward (synthetics or herbal); they were in their 38-40 weeks for geststional age; they had no sensitivity to herbal medicines. Exclusion criteria: Participants who need to surgery or stronger analgesics, or experience the side effects.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Severity of pain. Timepoint: 1 hour after usage of drug. Method of measurement: visual analogue scale. | — |
Secondary
| Measure | Time frame |
|---|---|
| Duration of pain. Timepoint: 1 hour after usage of drug. Method of measurement: upon hour and minute.;Side effects. Timepoint: 1 hour after usage of drug. Method of measurement: Patients' side effects based on their statements. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Masoumeh Simbar
Shahid Beheshti University of Medical Sciences
Outcome results
None listed